Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004688
Status:
COMPLETED
Last Update Posted:
2015-03-25
First Post:
2000-02-24
Brief Title:
Phase II Study of Carmustine Streptozocin and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
Sponsor:
Emory University
Organization:
FDA Office of Orphan Products Development
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Brain Tumor |
| Anaplastic Astrocytoma |
| Anaplastic Oligodendroglioma |
| Mixed Gliomas |
| Glioblastoma Multiforme |
Keywords:
| Name | View |
|---|---|
| recurrent adult brain tumor | View |
| adult anaplastic astrocytoma | View |
| adult anaplastic oligodendroglioma | View |
| adult brain stem glioma | View |
| adult brain tumor | View |
| adult glioblastoma multiforme | View |
| adult infiltrating astrocytoma | View |
| brain tumor | View |
| genetic condition | View |
| miscellaneous sitesterms | View |
| mixed gliomas | View |
| nervous tissue tumors | View |
| oncologic disorders | View |
| rare disease | View |